For more information about becoming an Investor, please contact:

Craig Richard
President & CEO

(813) 518-2620

Verséa Health

Verséa Health is a diversified life-science company committed to delivering innovative, high-value diagnostic and therapeutic solutions set to improve health care quality and access.

Through strategic industry partnerships we are continuously developing and commercializing products and services that are enhancing clinical management and treatment decisions, leading to better patient care.

Sean Fetcho

Sean Fetcho is the co-founder and CEO of Verséa Health, Inc., a global healthcare company committed to transforming scientific discoveries into applicable health and wellness solutions.

Sean’s shared passion for the evolving healthcare industry and for building early-stage companies prompted him to drive explosive growth for Verséa Health over the past few years.

Prior to Verséa Health, Sean’s roster of early stage and start-up companies includes multiple industries spanning from Agrotech, online consumer magazines and finance.

Sean successfully created, launched, and oversaw 8 highly successful print and digital publication that targeted oncology, pain management and cardiology professionals, all of which remain in circulation today. He was then recruited into a Continuing Medical Education (CME) company where Sean developed and executed on new revenue streams that helped structure the business for an exit. Within 3 years, Aventine (PAINWeek) sold to a publicly traded company on the London Stock Exchange.

Sean Fetcho
Co-Founder and CEO